ArticleBMC oral health2026

Therapeutic potential of low-dose rosiglitazone in periodontitis: attenuation of inflammation and bone loss through macrophage reprogramming.

Li-Na Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.